CBOA_2019_PreparedNow-8720-scaled-1-555x

BIOLOGICAL WARFARE TESTING

In partnership with The Defense Threat Reduction Agency [DTRA]

The Defense Threat Reduction Agency enables the Department of Defense, the United States Government and International partners to counter and deter weapons of mass destruction and improvised threat networks.

Paratus Diagnostics has been under contract with the US Defense Department since 2016 developing portable diagnostic and detection technologies for future warfighters as well as domestic threats.


In August 2019, Paratus was invited to participate in the Chemical and Biological Operations Assessment (CBOA) where emerging technologies can gain feedback from real warfighters using their technology in realistic scenarios. Our PreparedNow® System received very positive feedback from service members who cited the technology’s ease of use and simple user interface.


We are continuing to advance our point-of-care technology platform in order to meet diagnostic challenges both on and off the battlefield. 

 

©2021 by Paratus Diagnostics LLC. Paratus Diagnostics is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, and meets the requirements to perform high complexity tests. CLIA Registration 45D2190910.